Sexual function draws on a complex network of peripheral and central neural pathways. The standard focus on erectile difficulties and peripheral therapies has been highly successful clinically but there are many unresolved issues in men and newly discussed issues in women that will likely benefit from improved understanding of the central nervous system and sexual function. The spectrum of future therapies, based on evolving central neurophysiological understanding, will include the management of problems related to orgasm, ejaculation, desire, motivation, anxiety, and pleasure. This new range of therapies will employ old and new neurochemicals and pathways singly or in combination. The capability of hormones to modulate many of the sexual pathways will also contribute to the rise of multiagent therapy. The expanded understanding, in combination with enhanced imaging technologies, will renew the role of diagnosis and cause-specific treatment.
Introduction
Although, today, most neuroscientists say it is axiomatic that the phenomena of mind result from the operation of the brain, they could not tell you how. 1 Is there need for another synthesis of the available information on the pathophysiology of erectile function? Do we need another primer on penile anatomy? Can we appreciate the new details of the genomics of penile smooth muscle? Is there a better way to show the wonders of nitric oxide and phosphodiesterase inhibitors? Is our knowledge of the central nervous system (CNS) ready for the kind of detailed review that has been repeatedly given to the periphery?
Clearly, our understanding of the CNS and sexual function is only ready for an impressionistic overview of the machine. In keeping with the modest understanding of CNS erectile physiology, this review will sketch some of the newer information on what is known of the CNS and sexual function and how it fits together.
Conceptual framework updated
Sexual function is dominated by imagination. Just imagine an 18-y-old man, engaged in the erotic pursuit of a lovely young woman. His eyes are closed. He is immersed.y 'Bang', a car door slams, the front door of the house opens. The young woman's mother is standing there. The 18-y-old's erection is no longer. At an age when it takes just a moment of daydreaming to create excitement and erection, the balance of control is so fragile that in a moment it can all come crashing down. That is the power of imagination. We all know it on some level, but we are condemned to misunderstand it until it is pointed out to us. (Those who cannot remember the past are condemned to repeat it. George Santayana . ) We all have a personal view and experience of sex and sexuality and through this the opportunity for insight into sexual function and dysfunction. At the same time as we learn about complex behavioral and physiological functions by looking at ourselves, we are also constrained by a deep reluctance to face the objectivity of the camera turned inwards.
That little exercise demonstrated one important input to the control of sexual function and some of its properties. We learn that imagination is an important and powerful stimulant; that the negative side of the balance sheet carries more weight than the positive; that in a crowd, although we might have intellectual awareness of excitement, it is not proper to actually exhibit it.
Recent developments in medical imaging have been applied to mapping sexual function with the result that we can begin to look at anatomic representations of sexual processing in the CNSF even imagination.
The simple scenario of the young lovers and the exercise in imagination that recaptures the scene also demonstrate something else about our sexual wiring. We can imagine a stimulating and then stressful situation without actually embarrassing ourselves in public. There is a filter for appropriateness even though our limited scientific understanding can only describe this as an abstract quality. The decision, 'is now the right time for sex?', may be vital. Sex in the path of a charging rhinoceros is not conducive to the preservation of participating DNA and it is the medial amygdala that provides this service.
The medial amygdala 'organizes the appetitive phase of recognition of an appropriate partner and sexual arousal'. 2 We know this from complex behavioral studies in rats combined with stereotactic lesioning and direct brain injection studies. We know that there are a number of phylogenetically conserved peptide neurotransmitters, including vasopressin and oxytocin, which are closely associated with these mechanisms.
The logic of CNS organization means it should be no surprise that the proposed roles of nearby structures relate to reward and learned aspects of sexual behavior (imagination-permission-pleasure). Nature, or the grand architect, put the means to find sexual reward next to the means to appreciate the sexual reward and used common neurotransmitters. These links reinforced the functions and linked them to provide some positive feedback. In fact, it has become evident that the overall schema of the brain contains many such beautiful economies of effort and space.
A barrier to our understanding has always come from the apparent conflict between the apparent anatomic and physiological precision of the brain in some regards and the functional fuzziness of it in other respects. We know that a small volume stroke can produce language defects of astonishing subtlety, suggesting that function is localizedFbut we have also discovered that recovery of adjacent tissue can recapture some of that functionFsuggesting that function may also be somewhat arbitrarily regionalized. 3 So, in the representation of brain areas vital to sexual function some specificity is to be expected and it may be possible to identify specific pathways and neurochemicals. But, recognizing the necessity for multiple and overlapping systems, there will generally be areas involved (nuclei, tracts, bodies) rather than individual neurons. It is unlikely that something as vital to survival as sex would be trusted to single structures without redundancyFwe even have two nervi erigentes, a 100% redundancy, in anticipation of the advent of radical prostatectomy! But while our understanding of the CNS remains overwhelmed by the comparative complexity of the brain, the time may come when we can resolve specific functions down to small clumps of neurons and unique receptor subtypes. At present we believe these to be distributed in anatomical space and multiple in terms of neurotransmitters and receptors. Or we may have the technology to unravel the complexity of distributed processing served by brain regions, multiple neurons and multiple interconnections.
Think about complexity for a minute. It is no wonder we have an excellent understanding of the periphery. We can see the penis, we can see it respond to a sexual stimulus. Not seeing the vagina has been a problemFand we are just learning to get around that one in our scientific inquiries. Not seeing the results of brain functionFexcept indirectly is a huge problem. Not just because we have to be very deductive as we learn about it but because it is of vast complexity. As an example, there are on average 19 billion neocortical neurons in women and 23 billion in men. 4, 5 And this is only 30% of the number that form during gestation, and involute by birth. 6 Since interneurons account for approximately 15-30% of the total population of neurons, the possibilities for interconnectivity are very large and the mathematical description of the number of possible pathways is astronomical. 7 Interneurons provide the possibility of distributed function and complex processing. Further to add to the complexity, interneurons are not only connected by chemical synapses (unidirectional connections), but they may also form electrical synapses through gap junctions (bidirectional). Interneurons are biochemically heterogeneous (mostly GABAergic but also expressing a number of different neurotransmitters or their synthesizing enzymes, neuropeptides and calciumbinding proteins). There may be two types of electroneurochemical transmission: wiring transmission (classical type of neural transmission based on the physical substrate of neural chains) and volume transmission (consisting of chemical signals diffusing in the extracellular fluid and reaching receptors on neuronal cells located far away from the signal release site). 8 Given the complexity of cortical circuits, it is currently impossible to draw a diagram of cortical microcircuitry that is valid for anything except small cortical areas. Some connectionists believe that it may not be possible to accurately model the brain's neural architecture. 9 Others predict that eventually neurons may not be viewed as independent processing units but as members of subsets of networks where their role is mapped in space-time coordinates in relationship to the other neuronal members.
However, the CNS circuitry detail is arranged the inhibitory sides of the equations at almost any level are dominant. 11 Conceptually, it seems almost universally accurate to portray control of sexual function as a balance of erectogenic and erectolytic influences. This balance is common in simpler autonomic systems and permits subtle changes in set point, equilibration at high or low levels of activation and time-dependent variations in balance. There is a preponderance of inhibitory influence seen in the spinal cord as well. Possibly, man has the greatest presence of central inhibitory controlFand this is one over-riding issue we have failed to address to this point in current therapies of sexual dysfunction. The general schema for sexual systems that link central and peripheral sites includes a vital level of hard wiring and organization in the spinal cord. Recent evidence has pointed to the probability that ejaculatory function as well as genital vascular response may undergo significant regulation in the cord itself. The scholarly descriptions of detailed organization of neural components of female 12 and male 13 sexual systems are best covered in dedicated reviews.
CNS or psychogenic?
Over the last century we relied on the latest medical advance to guide our perception of the medical basis of sexual dysfunction. When psychiatry and psychology gained strength in the first half of the 20th century, all impotence was explained on the basis of psychogenic problems. In fact, we are still laboring under the distortions imposed by the persistence of this label.
14 Psychogenic meant 'in your head' and implied the possibility of correction by psychotherapy and nonorganicity. A sophisticated interpretation of psychogenic today would include the inevitability that the events of the CNS and mind are based on biochemical and cellular processes. So it is not reasonable to continue to contrast psychogenic and organic etiologies of sexual dysfunction on the basis that only organic implies treatability by drugs or to confuse psychogenic with a lack of severity. Psychogenic has been misused to imply either the imaginary nature of the problem or that drugs have little or no role. Since the distinction between organic and psychogenic is not clearly defined, it is not testable and it seems perverse to continue to use it.
The contrast between organic and psychogenic causes for ED is typical of the thinking of the 1970s and 1980s where vascular diseases and the vascular basis of penile erection were under great scrutiny. Vascular problems became understandable and even treatable. Much of the driving force for this was entirely outside the scope of ED, as heart disease was recognized as a great medical crisis. The understanding and treatment of CNS disease progressed significantly over the same period but the complexity factor held back development of science relevant to ED until the 1990s. Looking forward one can imagine that with the current level of sophistication in science, the understanding of CNS disease will grow rapidly and with great diversity at the same time as cardiovascular understanding begins to decelerate as it reaches many significant goals. This understanding will have great implications for sexual dysfunction management and the interface between sexual biology and behavior. 15 As we recognize the contributions of CNS dysfunctions to sexual dysfunction CNS-based therapies will become as logical as phosphodiesterase inhibitors are now in the treatment of vascular-based penile smooth muscle dysfunction.
Pathways updated
The importance to reproductive function of the medial preoptic area (MPOA) of the midbrain has been shown in many studies. Neurons in the MPOA have been shown to regulate timing aspects of female rat copulatory behavior. This is probably achieved by regulation of vaginal and cervical stimulation. It is possible that both male and female sexual behaviors are regulated by similar neural substrates in the MPOA. 16 The MPOA links through periaqueductal gray (PAG) to the nucleus paragigantocellularis (nPGi) and has known importance in other vital regulatory functions such as blood pressure and respiratory control. It has recently been examined to confirm the presence of a linked neural pathway using typical tracing techniques and establish the potential for sex hormone modulation. 17 The presence of a high percentage of neurons with androgen or estrogen receptors in a linked pathway with established importance in copulatory function is highly suggestive that this is one of the important pathways linking higher centers with the spinal cord and peripheral genital tissue. Evidence also exists showing that neurons originating in the nPGi terminate in lumbosacral spinal cord neurons that go on to innervate pelvic viscera. It is well to recognize that while finding sex steroid receptors in this pathway is suggestive more persuasive clarification would come from the demonstration of functional modulation of the pathway by these steroids. Simply putFare these receptors hooked up?
Some recent animal data update some wellestablished information on penile erections in rapid eye movement (REM) sleep. 18 Both sleep generation and copulatory mechanisms are associated with the preoptic areaFspecifically the lateral preoptic area (LPOA). These data also suggest divergence in sexual and sleep erection pathways in that LPOA lesions only ablated sleep erections.
CNS neurotransmitters update
New studies have confirmed the role of dopamine (DA) in the MPOA in promoting erections. Increased levels of dopamine in the MPOA increased two types of erections (reflexive and noncontact (NCE)) in rodents. 19 The MPOA has been held as one of the prime sites, along with the paraventricular nucleus (PVN) and possibly some spinal centers, for action of the dopamine agonist apomorphine in facilitating erections. Human evidence of the effects of dopamine agonism in the erectile pathway derives from clinical trial responses to sublingual apomorphine. 20 The complexity of the neural control of erection is such that it is only when a compound is applied clinically in man that it is possible to say that the theory works and has clinical utility. Apomorphine has now been extensively studied and prescribed and is an accepted safe and effective treatment for some men with ED. Although most of the evidence for site of action in humans is derived from the extensive body of animal research confirmation of the functional importance of the PVN and MPOA in male and female human sexual response may be found in the recent imaging studies using functional magnetic resonance (fMRI) techniques. Centrally and experimentally, dopamine has an impact on the perception of reward (more is better) and the implications of this in the context of sexual pleasure or reward in human males and females are not yet fully investigated. As a first glimpse, it is possible to say that apomorphine has no impact on conventional measures of male sexual desire in men with normal desire. The data from female subjects are scant, but there are indications that dopaminergic treatment (apomorphine) impacts positively on general measures of sexual function in certain women.
Cells of the MPOA have high densities of alpha2-noradrenergic receptors, as well as DA receptors. Studies show that the effects of DA in the MPOA are most likely facilitated by the activation of alpha2 (inhibition) and alpha1 (excitation) adrenoceptors due to cross talk within CNS catecholamine systems. 21 Gamma aminobutyric acid (GABA)(A) receptor agonism in the PVN can reduce both pharmacologically (apomorphine) and physiologically induced (NCE) erections. Increased GABAergic activity in the paraventricular nucleus provides a mechanism to balance (inhibit) proerectile signaling. 22 Other candidates for inhibitory control are serotonin (5-HT) and thyrotropin-releasing hormone (TRH). Both 5-HT and TRH (intrathecal) exhibit inhibitory effects on penile erection through common or parallel sets of neurons. 23 5-HT and TRH activity modulation may therefore be expected to have potential benefit for erectile function if suitable compounds and routes of delivery can be found.
Oxytocin, long associated with reproductive and erectile pathways, has been shown to be capable of inducing erection when introduced into the hippocampus (in the rat!). Intracavernous (systemic) oxytocin was not effective. 24 The potential for oxytocinergic compounds that cross the blood-brain barrier and can be delivered readily has yet to be fully explored.
Certain peptide analogs (EP peptides) of hexarelin, a growth hormone (GH) releasing peptide, have been found to induce penile erection. EP peptides are thought to act in the PVN and influence oxytocinergic neurons in a similar pathway to dopaminergic and oxytocinergic agonists. 25 This action of some EP peptides in inducing penile erection is comparable to that of apomorphine and oxytocin and has a different structure-activity relationship for proerectile activity compared with the other biological actions (GH release and eating behavior) of these compounds. When other EP peptides prevent penile erection, it is associated with a reduction in the increase in nitric oxide (NO) production that occurs with proerectile stimulation. 26 The expression of inducible NO synthase (iNOS) increases with age in the PVN and MPOA and in regions known to control the synthesis and release of gonadotropin-releasing hormone (GnRH) and oxytocin. iNOS, and hence increased NO, may impact serum testosterone, spermatogenesis, and copulatory function in the aging male animal. 27 Further evidence of the importance of NO in central signaling related to erectile function resulted from a series of experiments designed to alter CNS NO activity. 28 Manipulation of NO or cGMP levels altered MPOA triggered intracavernous pressure response through CNS not peripheral mechanisms.
The melanocortins have received further scrutiny and the MC4 receptor (MC4R) appears to be most responsible for the stimulation of penile erection (and appetite control). 29 Small molecule analogs active at the MC4R have been assessed and one such is the second modern centrally active compound to enter formal human studies. 30 These are believed to work through the familiar hypothalamic pathways and have the rapidity of response that should become familiar with CNS drugs for erection. Efficacy has been shown at various dose levels and the results of phase III human clinical trials will be important.
Imaging update
Given the complexity of structural-functional relationships in the CNS, it is inevitable that imaging Sexual and generally pleasant imagery is primarily associated with activation in the dominant or L4R brain hemisphere. Conversely, unpleasant imagery, phantogeusia, is generally associated with the contralateral or R4L brain hemisphere. And as the imagery shifts from good to bad, so the preponderance of activation shifts. 31 We know this from fMRI and derivative techniques.
The functional neuroanatomy of the brain during sexual arousal has been assessed with blood oxygenation level dependent (BOLD) fMRI. 32 Visual sexual stimulation (VSS) was compared with neutral stimulation and the occipital cortex was more stimulated during VSS. Half of the normal volunteers studied showed significant activation in the inferior frontal lobe, cingulate gyrus, insula gyrus, corpus callosum, thalamus, caudate nucleus, globus pallidus, and inferior temporal lobe during VSS. VSS response in hypogonadal patients was decreased and trended to improve with testosterone supplementation. fMRI evaluation of VSS in men with ED showed a restoration of a pattern similar to potent men when the men with ED were treated with apomorphine. The methodology of these studies is different but evidence of activation associated with penile tumescence has been documented in the right subinsular region including the claustrum, left caudate and putamen, right middle occipital and middle temporal gyri, bilateral cingulate gyrus, right sensorimotor and premotor regions and in the right hypothalamus. 33 Evidence from imaging in women with complete spinal cord injury (SCI) at the midthoracic level is particularly provocative. Using positron emission tomography (PET) and MRI techniques, various sexual and somatic sensory pathways were tested and compared in women with and without SCI. As expected, foot stimulation is blocked in SCI but normal women show activation of the somatosensory thalamus. Cervical self-stimulation increased activity in the region of the nucleus of the solitary tract, which is the brainstem nucleus to which the vagus nerves project even with SCI suggesting that vagus nerves can convey genital sensory input directly to the brain in women. 34 This concept is supported by animal studies and suggests the presence of at least four distinct pathways for the communication of genital signals in women: clitoral, perineal and inner thigh via the pudendal nerves, cervix and proximal three-fifths of the uterus via the hypogastric nerve, vagina, cervix, and perineal skin via the pelvic nerves, and now cervical and deep pelvic via the vagus.
Sexual arousal from VSS (compared with neutral stimulus) has been observed using PET techniques in normal young men. Activation was seen of bilateral (right4left) inferoposterior extrastriate cortices, of the right inferolateral prefrontal cortex and of the midbrain. 35 In other PET studies, VSS and documentation of arousal were compared with evaluated signals. The claustrum (unclear function) was significantly activated as were paralimbic areas (anterior cingulate gyrus, orbito-frontal cortex), in the striatum (head of caudate nucleus, putamen), and in the posterior hypothalamus. Decreased signal was patchy in temporal areas. 36 Mapping human sexual response has some significant potential benefits aside from making excellent material for learned communications. Visualization of abnormal responses or functional anatomy will assist in the classification of the elusive CNS states that contribute to sexual dysfunction. Conversely, the impact of therapies on these CNS abnormalities may be imaged and possibly measured.
Orgasm update
Consistent with the PET-MRI studies reported above, as many as 50% of previously orgasmic women with SCI can continue to achieve orgasm. 37 PET techniques (semiquantitative 99m Tc-HMPAO) have been applied to the study of orgasm in healthy young men. Blood flow decreases during orgasm. The exception is in the right prefrontal cortex, where the cerebral blood flow increases. 38 There is no literature cited linking orgasm and new-onset cerebrovascular accident (CVA), but it is conceivable that this could contribute to sudden death in flagrante delicto!
The literature on the neurophysiological basis for orgasm contains scant new material. Probably on a cultural basis this is one of the least discussed aspects of male human sexual function but it is also an issue of pivotal importance to the management of many women with orgasmic problems as a primary complaint. In all probability, the physiological basis of aspects of sexual function that have relevance to pleasure, not merely procreation, will receive close attention now that the study of female sexual dysfunction (FSD) is receiving attention. A majority of men still have little understanding of the relative independence of erection and orgasm. The decline in parameters and experience of orgasm and ejaculation with age is also well established but little known to patients.
Plasma prolactin (PRL) concentrations (but not testosterone) increase for about an hour following orgasm (masturbation and intercourse) in both men and women. The equivalent stimulation but without orgasm leaves PRL levels within the normal range. 39 In other contexts (experimental and clinical) elevated levels of PRL are associated with reductions in sexual activity. This may suggest that the surge in PRL post-orgasm may have a role in suppressing sexual behavior through a feedback process that is systemic but probably acts centrally. This may represent a PRL-mediated neuroendocrine reproductive reflex. A case study adds detail to this concept in that a man who was able to experience multiple (3) orgasms in quick succession was shown not to have any elevation in PRL. 40 Orgasm increases blood pressure, heart rate, plasma catecholamines and prolactin. After sexual abstinence, higher serum testosterone was seen but there was no impact on the other measured sex hormones. 41 In a more traditional deductive methodology, EEG evaluations of men with orgasmic aurae suggest that this is dominantly represented in the right hemisphere (87%). 42 Neurologists may be able to infer the most likely side for an epileptogenic focus if a preictal aura is orgasmic, urologists and sex researchers may expect imaging studies to emphasize right-sided changes during orgasm.
Update on ejaculation
The most significant recent addition to the understanding of the importance of spinal events in sexual function comes from a study where a population of lumbar spinothalamic cells have been found to be essential to the generation of ejaculatory behavior. 43 It is believed that these cells, which express neurokinin-1, relay ejaculation-related signals from reproductive organs to the brain. No other aspects of sexual behavior are altered if this population of cells is destroyed. Further work is needed to establish the human implications of this concept and how central and peripheral efferent and sensory signals integrate with the experience of ejaculation.
Other studies have shown that certain central structures (nucleus accumbens (NA)) are functionally altered by the experience of even just one ejaculation. 44 This may have implications in sexual motivation and reward.
Horses are not noted for the subtlety of their sexual responses although they do have ejaculatory latencies similar to the average man at around 85 s (ejaculation latency B90 s). The evidence from measurements of ejaculatory and erectile latency suggests that the spinal networks subserving ejaculation may be more fixed. 45 In particular, ejaculation latency does not vary between natural and assisted breeding whereas erectile parameters do.
Motivation update
In rodent experiments, it is possible to dissect components of sexual activity and they are given names that are broadly suggestive of recognizable human behaviors. Motivation in rats must be operating at a more basic level than that which drives man, but the appeal of a drug that would prolong the duration of copulation would seem to be immediately recognizable. The lucky experimental candidates were sexually sluggish male mice and they responded to the intracerbroventricular injection of galanin. No other changes in sexual performance were identified. 46 Further investigation of the galanin system has failed to reveal any important natural role.
In general terms, DA is supportive of copulation and 5-HT is inhibitory. DA is also involved in the reward from sexual activity. DA is released in the MPOA at the time of ejaculation (5-HT is not) and changes in DA and 5-HT in different areas of the brain may promote copulation and sexual satiety, respectively. 47 Testosterone enhances DA release in the MPOA at rest and with sexual challenge possibly by upregulating NOS, which increases NO thereby increasing DA release. The same pattern of copulatory activity promoting DA release in the MPOA and the enhanced effect of the presence of sex hormones is seen in female rats. Longer lasting changes may be seen through the postcopulatory effects of gene expression and this expression increases with increased sexual experienceFeffectively changing the phenotype of certain cells in sexually experienced animals.
Imagination update
The impact of imagination on human sexual behavior has been measured. In healthy middle and older married couples imagination (about other women), wife's desire for sex and erectile competence were universal determinants of sexual activity. 48 Whereas, the health of the male subjects and marital satisfaction appeared to be more culturally variable in their impact.
Imagination, here known as creative-dynamic image synthesis (CDIS), has been compared with the benefit of yohimbine and placebo in men with erectile dysfunction of no evident organic cause. 49 Measures of potency were found to improve more with CDIS than with yohimbine or placebo. Based on this study claim 'creative-dynamic image synthesis is a potent initiator of erections in men with psychogenic erectile dysfunction, has no known side effects and is very cost-effective' Phase III studies and preparation of an NDA are the obvious next steps. In certain men, enhancing the central proerectile signal by enhanced imagination or pharmacological means will reasonably be expected to enhance the erection. More signal at the level of the periphery causes better erection as is seen in postprostatectomy patients (where two nervi erigentes are better than one or none), reversible nerve lesioning experiments and with graded stimulation (imaginationoVSSovibratory stimulation).
The perspective of the imagination is also important. Imagery or imagination is more effective in supporting penile erection if it is participant based rather than spectator based. 50 The same series of studies documented the negative effects of habituation to the sexual stimulusFa factor that is intuitive to humans with experience of monogamous sexual activity. When attention is measured, VSS is more engrossing than film with no sexual content and the arousal is related to the extent to which the subjects were entertained by visual stimulation. 51 
Olfactory update
The four major categories of sexual stimulus have been said to be tactile sensation, visual input, imagination, and olfactory input. The effects of male, female, and neutral fragrance on provoked sexual response in women have been assessed. Sexual arousal and positive mood were more common in the periovulatory phase of the menstrual cycle. 52 Erotic fantasy was enhanced by male scent during the follicular phaseFand these effects occurred independent of any effects on mood. Male scent and fantasy are good for sexual excitement but will not rescue a bad mood!
Conclusions
In managing sexual problems, there has been a clear focus on erectile difficulties. As the spotlight moves towards female sexual problems and the broad potential of CNS understanding and therapy erection will remain a priority but other vital interacting issues will be increasingly important and therapeutically accessible. The spectrum of future therapies, based on evolving central neurophysiological understanding, will include the management of problems related to orgasm, ejaculation, desire, motivation, and pleasure. This new range of therapies will employ old and new neurochemicals and pathways and probably hormone modulation singly and in combination. These sexual problems exist, they have not been fabricated and there is no implication that new diseases will be generated for which new solutions can be provided. This is simply a statement about the complex physiology that governs our experience of sexual response and how much potential there is for errors of function and structure (from cells to whole organs and systems). No human physiological system yet has been investigated that remains flawless across time and whole populations. Therapy of problems in sexual life will be improved and expanded beyond the scope of peripheral therapy and counseling by the application of knowledge of the working of central aspects of sexual function.
